Skip to content

MEDICAL TECHNOLOGIES & SYSTEMS

Active
Private limited companyfounded 2016active for 10 yearsRue du Tchaurnia,M.-St-Blaise 47, 5560 Houyet, BelgiumKBO/BCE: BE 0660.821.507
Summary

MEDICAL TECHNOLOGIES & SYSTEMS has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,846 and a net result of €1,433. Equity has been growing by about 22% per year since 2019. Its solvency ranks better than 52% of 13,741 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.9% (low).

Overview

Official details

Source: KBO
Status
Active since 09-08-2016 Normal situation
Activity
Wholesale of pharmaceutical and medical goods NACE 46460
Establishment unit
2.257.839.306 5560 Houyet, since 05-10-2016
Financial year end
30 June
Peppol
Reachable since 30-01-2025

Board and ownership

Board
  • De Vriendt MyriamDirector · since 09-08-2016

Financial position

67 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.9%
Annual accounts to 30-06-2025
Gross margin
€28,660
▲ 13.2%
Turnover
≈ €150,000
estimated
Profit
€1,433
▼ 81.6%
Equity
€29,846
▲ 5.0%
Total assets
€68,801
▼ 35.6%
Score breakdownraises riskLiquidity: current ratio 1.68Profit of €1,433 (financial year 2025)lowers riskSize: total assets €68,801Show the evidence

Checked score

Score 2025
67 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 45% of micro companies in wholesale trade (NACE 46)
Financial strength · tick: 2024
Average
Solvency 68+16
equity 43.4% of total assets
Liquidity 42-18
short-term debt 56.6%
Profitability 40-8
return on assets 2.1%
Bankruptcy probability within 12 months
0.9% Low
0%0.5%1.5%4%10%≥ 25%

About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,899 companies, NACE 46, micro)
Last 24 months 12-2024: 0.5% 01-2025: 0.6%▲ +0.1 percentage points vs 12-2024 02-2025: 1.0%▲ +0.4 percentage points vs 01-2025highest value 03-2025: 0.2%▼ -0.8 percentage points vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025lowest value 09-2025: 0.2%● unchanged vs 08-2025lowest value 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.5%▲ +0.3 percentage points vs 01-2026 03-2026: 0.9%▲ +0.4 percentage points vs 02-2026 04-2026: 0.9%● unchanged vs 03-2026 05-2026: 0.9%● unchanged vs 04-2026 06-2026: 0.9%● unchanged vs 05-2026 07-2026: 0.9%● unchanged vs 06-2026 08-2026: 0.9%● unchanged vs 07-2026 09-2026: 0.9%● unchanged vs 08-2026 10-2026: 0.9%● unchanged vs 09-2026 11-2026: 0.9%● unchanged vs 10-2026
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.68 (1.31 in 2024), above the usual 1.5. Short-term debt is 56.6% of total assets. However, 56.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 52% of them on solvency, 40% on liquidity, 32% on profitability and 55% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Four signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 1.68
NBB · annual accounts
lowers risk · Size: total assets €68,801
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Profit of €1,433 (financial year 2025)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
1 day early
2024
on the day
2023
1 day early
2022
1 day early
2021
111 days early
2020
on the day
2019
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 30 January (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end03-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 5 profitable years in a rowprofit 2025: €1,433 5 years View

Recent changes

  1. · Gazette deed Incorporation
All 11 events

Comparable companies

These companies have the same main activity as MEDICAL TECHNOLOGIES & SYSTEMS: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €39,500 and €136,000, founded between 2014 and 2017.

CompanyTotal assetsGross margin
MEDICAL TECHNOLOGIES & SYSTEMS Houyet€68,801€28,660
NUTRICONCEPTS Ittre€68,880€25,658
HCPS Antwerpen€80,577€35,199
Key for Management and Translation Sint-Pieters-Leeuw€92,531€39,555
VAN LENT SYSTEMS BELGIUM Beveren-Kruibeke-Zwijndrecht€39,458€28,739
XMED Koksijde€136,494€40,016
NOREVA BE Gent€99,431€64,457
Full comparison

Key facts about MEDICAL TECHNOLOGIES & SYSTEMS

What is the company number of MEDICAL TECHNOLOGIES & SYSTEMS?
The company number of MEDICAL TECHNOLOGIES & SYSTEMS is 0660.821.507. The VAT number is the same number with BE in front: BE 0660.821.507.
Where is MEDICAL TECHNOLOGIES & SYSTEMS based?
The registered office is at Rue du Tchaurnia,M.-St-Blaise 47, 5560 Houyet.Company details
What does MEDICAL TECHNOLOGIES & SYSTEMS do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of MEDICAL TECHNOLOGIES & SYSTEMS?
The legal form of MEDICAL TECHNOLOGIES & SYSTEMS is Private limited company (BV).
When was MEDICAL TECHNOLOGIES & SYSTEMS founded?
MEDICAL TECHNOLOGIES & SYSTEMS was founded on 09-08-2016.
Is MEDICAL TECHNOLOGIES & SYSTEMS still active?
Yes, MEDICAL TECHNOLOGIES & SYSTEMS is an active enterprise in the KBO register.
What is the turnover of MEDICAL TECHNOLOGIES & SYSTEMS?
The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €28,660 and 33 comparable companies (NACE 464). It probably lies between €91,000 and €300,000.Financials
Is MEDICAL TECHNOLOGIES & SYSTEMS profitable?
In financial year 2025, MEDICAL TECHNOLOGIES & SYSTEMS made a profit of €1,433.
Where can I find the annual accounts of MEDICAL TECHNOLOGIES & SYSTEMS?
MEDICAL TECHNOLOGIES & SYSTEMS filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDICAL TECHNOLOGIES & SYSTEMS due?
MEDICAL TECHNOLOGIES & SYSTEMS must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.